Cost-effectiveness tool for G6PD RDTs

This cost-effectiveness tool developed by Angela Devine assesses the cost-effectiveness of using G6PD RDTs  and provides a model as an online tool for use in other settings. This model is only applicable primaquine and new models are being developed for tafenoquine. To access to the tool, visit the Cost effectiveness of G6PD screening online tool.